Clostridium difficile infection in patients with inflammatory bowel disease

Gastroenterology and Hepatology

Volumn 8, Issue 9, 2012, Pages 615-617

  Binion, David G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIDAXOMICIN; IMMUNOGLOBULIN G; METRONIDAZOLE; VANCOMYCIN;

ABDOMINAL PAIN; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COLON RESECTION; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG EFFICACY; ELDERLY CARE; ENTERITIS; ENVIRONMENTAL EXPOSURE; HAND WASHING; HEALTH CARE COST; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; HUMORAL IMMUNITY; MORBIDITY; MORTALITY; NOTE; NURSING HOME; OUTCOME ASSESSMENT; OUTPATIENT; OUTPATIENT CARE; RISK FACTOR; TREATMENT RESPONSE; ULCERATIVE COLITIS;

EID: 84868005722     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Ananthakrishnan AN, Issa M, Binion DG. Clostridium difficile and inflammatory bowel disease. Med Clin North Am. 2010;94:135-153.
2. Ananthakrishnan AN, Binion DG. Impact of Clostridium difficile on inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2010;4:589-600.
3. Lucado J, Gould C, Elixhauser A. Clostridium difficile infections (CDI) in hospital stays, 2009. HCUP Statistical Brief #124. Rockville, Md: Agency for Healthcare Research and Quality; 2012. http://www.hcup-us.ahrq.gov/reports/ statbriefs/sb124.pdf.
4. Dubberke E. Clostridium difficile infection: the scope of the problem. J Hosp Med. 2012;7(suppl 3):S1-S4.
5. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med. 2000;342:390-397.